Latest Insider Transactions at Cme Group Inc. (CME)
This section provides a real-time view of insider transactions for Cme Group Inc. (CME). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CME GROUP INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CME GROUP INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 14
2021
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
SELL
Payment of exercise price or tax liability
|
Direct |
363
-0.85%
|
$68,244
$188.85 P/Share
|
Sep 14
2021
|
Kevin Kometer Sr MD Chief Information Office |
SELL
Payment of exercise price or tax liability
|
Direct |
385
-0.52%
|
$72,380
$188.85 P/Share
|
Sep 14
2021
|
Ken Vroman Chief Transformation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
88
-0.82%
|
$16,544
$188.85 P/Share
|
Sep 14
2021
|
Julie Winkler Sr MD Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
321
-1.26%
|
$60,348
$188.85 P/Share
|
Sep 14
2021
|
John W. Pietrowicz Sr MD Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
470
-0.98%
|
$88,360
$188.85 P/Share
|
Sep 14
2021
|
Sean Tully Sr MD Global Hd Rates & OTC |
SELL
Payment of exercise price or tax liability
|
Direct |
478
-2.04%
|
$89,864
$188.85 P/Share
|
Sep 14
2021
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Payment of exercise price or tax liability
|
Direct |
363
-2.53%
|
$68,244
$188.85 P/Share
|
Sep 14
2021
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
62
-0.33%
|
$11,656
$188.85 P/Share
|
Sep 14
2021
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
342
-0.83%
|
$64,296
$188.85 P/Share
|
Sep 13
2021
|
Martin J Gepsman Director |
SELL
Open market or private sale
|
Direct |
1,000
-3.93%
|
$188,000
$188.53 P/Share
|
Sep 07
2021
|
Martin J Gepsman Director |
SELL
Open market or private sale
|
Direct |
1,000
-3.78%
|
$194,000
$194.25 P/Share
|
Aug 30
2021
|
Martin J Gepsman Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.22%
|
$201,000
$201.02 P/Share
|
Aug 24
2021
|
Sean Tully Sr MD Global Hd Rates & OTC |
SELL
Open market or private sale
|
Direct |
5,000
-17.56%
|
$1,000,000
$200.2 P/Share
|
Aug 23
2021
|
Martin J Gepsman Director |
SELL
Open market or private sale
|
Direct |
1,000
-3.51%
|
$201,000
$201.37 P/Share
|
Jun 25
2021
|
Timothy S. Bitsberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+4.9%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Charles P Carey Director |
BUY
Grant, award, or other acquisition
|
Indirect |
917
+16.49%
|
$199,906
$218.12 P/Share
|
Jun 25
2021
|
Michael G. Dennis Global Head of Fixed Income |
BUY
Grant, award, or other acquisition
|
Direct |
551
+30.16%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Dennis Chookaszian Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+14.07%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Ana Dutra Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+7.89%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Martin J Gepsman Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+1.9%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Patrick W Maloney Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+30.31%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Robert J Tierney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+22.77%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Patrick J Mulchrone Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+1.08%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Elizabeth A Cook Director |
BUY
Grant, award, or other acquisition
|
Indirect |
551
+2.72%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
William W Hobert Director |
BUY
Grant, award, or other acquisition
|
Direct |
917
+1.11%
|
$199,906
$218.12 P/Share
|
Jun 25
2021
|
Daniel R Glickman Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+3.55%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Phyllis M Lockett Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+22.77%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Daniel G Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+22.77%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Dennis Suskind Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+15.03%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Deborah J Lucas Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+17.73%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
William R Shepard Director |
BUY
Grant, award, or other acquisition
|
Indirect |
917
+0.46%
|
$199,906
$218.12 P/Share
|
Jun 25
2021
|
Howard J Siegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
917
+1.12%
|
$199,906
$218.12 P/Share
|
Jun 25
2021
|
Rahael Seifu Director |
BUY
Grant, award, or other acquisition
|
Direct |
551
+30.37%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Terry L Savage Director |
BUY
Grant, award, or other acquisition
|
Indirect |
551
+2.91%
|
$120,118
$218.12 P/Share
|
Jun 25
2021
|
Larry G Gerdes Director |
BUY
Grant, award, or other acquisition
|
Direct |
917
+2.43%
|
$199,906
$218.12 P/Share
|
Jun 14
2021
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
SELL
Open market or private sale
|
Direct |
4,092
-8.79%
|
$879,780
$215.31 P/Share
|
Jun 14
2021
|
Howard J Siegel Director |
SELL
Open market or private sale
|
Direct |
1,500
-1.84%
|
$322,500
$215.0 P/Share
|
Jun 11
2021
|
Elizabeth A Cook Director |
SELL
Grant, award, or other acquisition
|
Indirect |
1,000
-2.51%
|
$214,000
$214.11 P/Share
|
Jun 09
2021
|
Elizabeth A Cook Director |
SELL
Open market or private sale
|
Indirect |
2,000
-4.55%
|
$432,000
$216.13 P/Share
|
May 27
2021
|
Julie Winkler Sr MD Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,500
-12.11%
|
$759,500
$217.0 P/Share
|
May 26
2021
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
SELL
Bona fide gift
|
Direct |
395
-0.84%
|
-
|
May 25
2021
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
SELL
Bona fide gift
|
Direct |
233
-0.49%
|
-
|
May 19
2021
|
Terrence A Duffy Chairman and CEO |
SELL
Open market or private sale
|
Direct |
29,000
-34.32%
|
$6,090,000
$210.83 P/Share
|
May 17
2021
|
Derek Sammann Sr MD Gl Hd Commodity & Option |
SELL
Bona fide gift
|
Indirect |
1,800
-10.17%
|
-
|
May 12
2021
|
Julie Holzrichter Sr MD Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
6,000
-14.12%
|
$1,278,000
$213.29 P/Share
|
Mar 25
2021
|
Sean Tully Sr MD Global Hd Rates & OTC |
BUY
Exercise of conversion of derivative security
|
Direct |
4,120
+12.64%
|
$222,480
$54.37 P/Share
|
Mar 16
2021
|
Ken Vroman Chief Transformation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
78
-0.72%
|
$16,146
$207.12 P/Share
|
Mar 15
2021
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
SELL
Payment of exercise price or tax liability
|
Direct |
2,732
-5.47%
|
$570,988
$209.09 P/Share
|
Mar 15
2021
|
Kathleen M Cronin Sr MD Gen Counsel & Corp Secr |
BUY
Grant, award, or other acquisition
|
Direct |
7,048
+12.37%
|
$1,473,032
$209.09 P/Share
|
Mar 15
2021
|
Sunil Cutinho Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,186
-7.19%
|
$665,874
$209.09 P/Share
|